Dipal Doshi

Dipal Doshi serves as Chief Executive Officer at Entrada Therapeutics. Entrada Therapeutics operates in the research sector with approximately 200.0 employees. The company is headquartered in New York, New York. Entrada Therapeutics generates annual revenue of 210782000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 2 executives at Entrada Therapeutics.
• • 6,952 executive contacts are available in New York.
• • Our database includes 201,469 c suite-level executives.

Salesforce Mimecast Outlook Microsoft Office 365 DigitalOcean Google Analytics Greenhouse.io Nginx Vimeo reCAPTCHA New Relic Google Tag Manager Mobile Friendly Google Font API Remote

biotechnology: pharmaceutical preparations health care biotechnology research intracellular therapeutics endosomal escape vehicle eev platform duchenne muscular dystrophy myotonic dystrophy type 1 therapeutic potential modular approach hemophilia treatment neuromuscular diseases innovative drug delivery oligonucleotide programs antibody-based therapies enzyme therapy cyclic peptides cell-penetrating peptides targeted protein therapy rare diseases biologics therapeutic index cellular penetration genetic disorders dystrophin production therapeutic efficacy patient-centric treatments clinical trials safety & tolerability neurodegenerative diseases biotechnology drug discovery functional dystrophin muscle wasting rna therapy pharmaceutical research disease-causing targets immune-mediated diseases speed to market patient advocacy equity in healthcare inclusive research clinical-stage development biopharmaceutical innovation target engagement pipeline expansion advanced therapies customized treatment programs sustainable healthcare solutions collaborative research diversity in biotech scientific excellence clinical-stage eev therapeutics intracellular delivery rare genetic diseases neuromuscular disorders oligonucleotide therapies immunology oncology central nervous system therapeutic innovation drug development healthcare providers patient-centric strategic partnerships vertex pharmaceuticals pierrepont therapeutics transformative therapies unmet medical needs biopharmaceutical industry innovative treatments genetic therapies healthcare engagement market research targeted marketing key opinion leaders modular platform disease focus areas health wellness & fitness hospital & health care

ND

Nathan Dowden President and Chief Operating Officer at Entrada Therapeutics

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

How can I contact Dipal Doshi?

Dipal Doshi's verified email address is available on MessageCEO. They currently work at Entrada Therapeutics. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Dipal Doshi lead?

Dipal Doshi is Chief Executive Officer at Entrada Therapeutics, a company in the research sector with 200.0 employees. The company is based in New York, New York.

What industry is Dipal Doshi in?

Dipal Doshi works in the research industry as Chief Executive Officer at Entrada Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Dipal Doshi's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Dipal Doshi's profile is kept up-to-date with the latest available information.

Last updated: April 6, 2026